Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
FDC Ltd. ( (IN:FDC) ) has provided an update.
FDC Ltd. has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application covering Fluconazole Tablets USP in strengths of 50 mg, 100 mg, 150 mg and 200 mg. The clearance enables FDC to market a generic version of the antifungal medicine in the United States, strengthening its presence in the key U.S. generics market and potentially expanding its revenue opportunities in the anti-infective segment.
More about FDC Ltd.
FDC Ltd. is an Indian pharmaceutical company engaged in developing, manufacturing and marketing formulations, including tablets and other dosage forms, for domestic and international markets, with a growing focus on regulated markets such as the United States.
Average Trading Volume: 7,327
Technical Sentiment Signal: Hold
Current Market Cap: 67.19B INR
Find detailed analytics on FDC stock on TipRanks’ Stock Analysis page.